Surajit Dhara

Title: Surajit Dhara: Innovator in Cancer Prognostics

Introduction

Surajit Dhara is a notable inventor based in Hanover, NH (US). He has made significant contributions to the field of cancer research, particularly in the area of prognostic markers for pancreatic cancer. His innovative work aims to improve patient outcomes through advanced predictive technologies.

Latest Patents

Surajit Dhara holds a patent for an invention titled "ATAC-array for prediction of disease-free survival in pancreatic cancer." This patent describes an array-based assay that focuses on transposase-accessible chromatin and prognostic molecular markers associated with treatment-resistant and early recurrent cancer. The technology aims to predict outcomes, such as the duration of disease-free survival, in cancer patients.

Career Highlights

Throughout his career, Surajit Dhara has worked with prestigious institutions, including Dartmouth College and Memorial Sloan Kettering Cancer Center. His experience in these organizations has allowed him to collaborate with leading experts in the field of cancer research.

Collaborations

Some of his notable coworkers include Christina Leslie and Steven D Leach. Their collaborative efforts have contributed to advancing research in cancer prognostics and treatment strategies.

Conclusion

Surajit Dhara's innovative work in cancer research, particularly through his patent on the ATAC-array, showcases his commitment to improving patient care and outcomes. His contributions to the field are invaluable and highlight the importance of innovation in medical research.